Arcutis Biotherapeutics, Inc. ARQT Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed October 28, 2025, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s return on invested capital?
- Arcutis Biotherapeutics, Inc. (ARQT) reported return on invested capital of -16.9% in Q3 2025.
- How has Arcutis Biotherapeutics, Inc.'s return on invested capital changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s return on invested capital increased by 82.7% year-over-year, from -97.6% to -16.9%.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s return on invested capital?
- Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s return on invested capital has grown at a -9.0% compound annual growth rate (CAGR), from -85% to -64%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.